Clinipace

Clinipace Worldwide Co-founder & CEO Jeff Williams to resign as CEO

Wednesday, October 18, 2017

Jeff Williams, Co-founder, President and CEO of Clinipace Worldwide, a global full-service CRO that he founded 14 years ago, has elected to move into an expanded advisory role with the company’s Board of Directors. He will be handing over his responsibilities to Jason Monteleone, who will assume the role of Chief Executive Officer. Williams will remain a Director and will focus on strategic initiatives on behalf of the Board of Directors. 

[Read More]

Clinipace Worldwide co-founders named E&Y Entrepreneur of the Year finalists

Thursday, May 7, 2015

Clinipace Worldwide, a global digital CRO, has announced Jeff Williams, CEO and co-founder, and Chris Porter, president and co-founder, have been named one of three finalists in the Health Care & Life Sciences category of the Ernst & Young Entrepreneur Of The Year 2015 Southeast Program, which includes Alabama, Georgia, North Carolina, South Carolina and Tennessee. The awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in areas such as innovation, financial performance and personal commitment to their businesses and communities.

[Read More]

Karyopharm Therapeutics enters agreement with Clinipace Worldwide

Thursday, April 10, 2014

Clinipace Worldwide, a global digital CRO (dCRO), has announced that Karyopharm Therapeutics, a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, has entered into a preferred provider agreement with Clinipace to manage several clinical programs, including oncology and wound healing.

[Read More]